Ocular Therapeutix
OCUL
#4777
Rank
C$3.16 B
Marketcap
C$14.40
Share price
-4.25%
Change (1 day)
-16.34%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2026 (TTM): -C$0.41 Billion

According to Ocular Therapeutix's latest financial reports the company's current earnings are C$52.03 Million. In 2025 the company made an earning of -C$0.37 Billion a decrease over its 2024 earnings that were of -C$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.41 Billion8.38%
2025 -C$0.37 Billion37.43%
2024 -C$0.27 Billion139.68%
2023 -C$0.12 Billion13.65%
2022 -C$98.75 Million984.05%
2021 -C$9.11 Million-95.79%
2020 -C$0.22 Billion80.19%
2019 -C$0.13 Billion44.01%
2018 -C$83.38 Million-5.38%
2017 -C$88.12 Million41.79%
2016 -C$62.15 Million12.47%
2015 -C$55.26 Million38.75%
2014 -C$39.83 Million115.12%
2013 -C$18.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
SurModics
SRDX
-C$15.58 Million-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
-C$17.04 Million-95.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
-C$0.23 Billion-44.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
C$0.21 B-153.95%๐Ÿ‡บ๐Ÿ‡ธ USA